Dalagon, Deborah N.
HRN: 13-28-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/18/2024
02/25/2024
IV
2.25g
Q6h
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes